Evidence map›Paper›PMID 35575506›Full record

ArticleMicrobiology spectrum2022

Raffinose Inhibits Streptococcus mutans Biofilm Formation by Targeting Glucosyltransferase.

So-Young Ham, Han-Shin Kim, Eunji Cha, Taehyeung Lim, Youngjoo Byun, Hee-Deung Park

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. α2-3-Sialylated Glycoproteins AttenuateInternational journal of molecular sciences · 2026
    Article
  2. Antibiofilm and antibacterial effects ofBiomaterial investigations in dentistry · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. 3 Biotech · 2025
    Review
  9. Effects of Tooth Desensitizers onInternational journal of molecular sciences · 2024
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

So-Young HamSchool of Civil, Environmental, and Architectural Engineering, Korea Universitygrid.222754.4, Seoul, South Korea.
Han-Shin KimDivision of Biotechnology, College of Environmental and Bioresource Sciences, Jeonbuk National University, Iksan, Jeonbuk, South Korea.
Eunji ChaSchool of Civil, Environmental, and Architectural Engineering, Korea Universitygrid.222754.4, Seoul, South Korea.
Taehyeung LimCollege of Pharmacy, Korea Universitygrid.222754.4, Sejong, South Korea.
Youngjoo ByunCollege of Pharmacy, Korea Universitygrid.222754.4, Sejong, South Korea.
Hee-Deung ParkSchool of Civil, Environmental, and Architectural Engineering, Korea Universitygrid.222754.4, Seoul, South Korea.ORCID 0000-0002-5769-335X
Korea University · KRJeonbuk National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Streptococcus mutans is a representative biofilm-forming bacterium that causes dental caries through glucosyltransferase (GTF) activity. Glucans are synthesized from sucrose by GTFs and provide binding sites for S. mutans to adhere tightly to the tooth enamel. Therefore, if a novel compound that interferes with GTF function is developed, biofilm formation control in S. mutans would be possible. We discovered that raffinose, an oligosaccharide from natural products, strongly inhibited biofilm formation, GTF-related gene expression, and glucan production. Furthermore, biofilm inhibition on saliva-coated hydroxyapatite discs through the reduction of bacterial adhesion indicated the applicability of raffinose in oral health. These effects of raffinose appear to be due to its ability to modulate GTF activity in S. mutans. Hence, raffinose may be considered an antibiofilm agent for use as a substance for oral supplies and dental materials to prevent dental caries.

Indexed as

Biological ProductsDental CariesAnti-Bacterial AgentsBiofilmsDental MaterialsGlucansGlucosyltransferasesHumansRaffinoseStreptococcus mutansAnti-Bacterial AgentsBiological ProductsDental MaterialsGlucansGlucosyltransferasesRaffinosebiofilmglucosyltransferaseraffinoseStreptococcus mutans

Identifiers

PMID35575506
PMCPMC9241737
OpenAlexW4280549879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.